Dongwha to register patent for a Quinolone derivative.

Published: 2005-08-12 06:55:00

Updated: 2005-08-12 06:55:00

Dongwha announced on Aug. 9 that the company completed a patent registration under the No. 0497942 for an optically active form of 7-pyrrolidine quinolin carboxylic acid derivative and its production process in Korea.

Dongwha made about 2 billion won of investment for the R&D of this Quinolon...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK